CSF Neurofilament Light Predicts Cortical Atrophy in Early-Onset Alzheimer’s
Personalized briefing
Discovery of the day · Neurology
Relationships of CSF biomarkers to cortical atrophy in early‐onset Alzheimer’s disease
Dear Damien Boorman, this is your personalized scientific intelligence briefing — curated for your work in Neurology.
Key finding
Medicine · Neurology
Discovery of the day
A new study demonstrates that cerebrospinal fluid (CSF) neurofilament light chain (NfL) levels are the strongest predictor of cortical atrophy in the early-onset Alzheimer’s disease (EOAD) signature, outperforming other CSF biomarkers. In 80 EOAD patients, researchers found that CSF NfL levels best predicted atrophy within the EOAD cortical signature, and that combining this biomarker with the atrophy measure explained more variance in cognitive impairment than either factor alone. For a neuroscientist studying central nervous system mechanisms of disease and treatment, this finding provides a clinically accessible biomarker to track neurodegeneration in a particularly aggressive form of Alzheimer’s, directly supporting your goal of using mechanistic understanding to improve patient well-being.
Novelty
91%
Rigor
85%
Significance
93%
Validity
82%
Clarity
90%
Advertisement
ScientificChina — The Global Marketplace for Scientific and Medical Equipments Start Browsing →
Your briefing is personalized based on your selected fields, keywords, and research interests.
